TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · major macro event coming up
BLTE

Belite Bio Inc

Healthcare · Biotechnology

166.70$ +0.4% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

Belite Bio Inc (BLTE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 792 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BLTE
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
58 95 118 118 116 152 164 156 282 781 811 792
56 90 114 114 111 147 159 151 277 494 522 502
55 88 112 – 109 32 157 149 157 353 – –
55 88 112 – 109 145 157 149 276 492 – –
– 0.9 – – – 0.6 – – 0.0 0.7 – –
– 3.3 – – – 4.0 – – 0.0 4.9 – –
4.8 4.2 3.8 3.8 3.6 6.3 6.1 6.5 8.3 10 15 15
4.8 3.6 3.8 – 3.6 6.1 6.1 6.5 8.1 9.9 15 15
– 0.3 – – – 0.3 – – 0.3 0.2 – –
53 90 115 115 112 146 158 150 274 770 796 777
– -72 – – – -108 – – -160 -185 – –
27 28 30 31 31 31 32 33 33 34 40 40

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?